← 產業報告目錄
Compounding Pharmacy Market, Share & Trends Analysis Report, By Products (Topical, Oral, Rectal, Nasal, Ophthalmic), By Therapeutic Areas, By Route of Administration, By Sterility Type, By End User, By Compounding Type, By Region, and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-27頁數 165報告編號 INSIGHTACE-51f4a89d82
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the Compounding Pharmacy Market worldwide was assessed at USD 14.79 Bn. Analysts project it will progress to USD 26.38 Bn by 2031, at a CAGR of 7.6% spanning 2024 to 2031.
Compounding Pharmacy covers creation of a pharmaceutical preparation of a drug by a licensed pharmacist to meet the unique needs of an individual patient, whether human or animal when a commercially available . Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Compounding Pharmacy Market Snapshot
Chapter 4. Global Compounding Pharmacy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Products Estimates & Trend Analysis
5.1. by Products & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Products:
5.2.1. Topical
5.2.2. Oral
5.2.3. Rectal
5.2.4. Nasal
5.2.5. Ophthalmic
Chapter 6. Market Segmentation 2: by Therapeutic Areas Estimates & Trend Analysis
6.1. by Therapeutic Areas & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Therapeutic Areas:
6.2.1. Pain Management
6.2.2. Hormone Replacement Therapy
6.2.3. Dermal Disorder
6.2.4. Nutritional Supplement
6.2.5. Other Therapeutic Areas
Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis
7.1. by Route of Administration & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
7.2.1. Oral
7.2.2. Topical
7.2.3. Parenteral
7.2.4. Other Routes of Administration
Chapter 8. Market Segmentation 4: by Sterility Type Estimates & Trend Analysis
8.1. By Sterility Type & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Sterility Type:
8.2.1. Sterile
8.2.2. Non-Sterile
Chapter 9. Market Segmentation 5: by End User Estimates & Trend Analysis
9.1. By End User & Market Share, 2019 & 2031
9.1.1. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
9.1.2. Pediatric
9.1.3. Adults
9.1.4. Geriatric
9.1.5. Veterinary
Chapter 10. Market Segmentation 6: by Compounding Type Estimates & Trend Analysis
10.1. by Compounding Type & Market Share, 2019 & 2031
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Compounding Type:
10.2.1. Pharmaceutical Ingredient Alteration (PIA)
10.2.2. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
10.2.3. Pharmaceutical Dosage Alteration (PDA)
10.2.4. Others
Chapter 11. Compounding Pharmacy Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Products, 2024-2031
11.1.2. North America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2024-2031
11.1.3. North America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.1.4. North America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Sterility Type, 2024-2031
11.1.5. North America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
11.1.6. North America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Compounding Type, 2024-2031
11.1.7. North America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
11.2. Europe
11.2.1. Europe Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Products, 2024-2031
11.2.2. Europe Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2024-2031
11.2.3. Europe Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.2.4. Europe Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Sterility Type, 2024-2031
11.2.5. Europe Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
11.2.6. Europe Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Compounding Type, 2024-2031
11.2.7. Europe Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Products, 2024-2031
11.3.2. Asia Pacific Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2024-2031
11.3.3. Asia-Pacific Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.3.4. Asia-Pacific Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Sterility Type, 2024-2031
11.3.5. Asia-Pacific Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
11.3.6. Asia-Pacific Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Compounding Type, 2024-2031
11.3.7. Asia Pacific Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
11.4. Latin America
11.4.1. Latin America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Products, 2024-2031
11.4.2. Latin America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2024-2031
11.4.3. Latin America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.4.4. Latin America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Sterility Type, 2024-2031
11.4.5. Latin America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
11.4.6. Latin America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Compounding Type, 2024-2031
11.4.7. Latin America Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Products, 2024-2031
11.5.2. Middle East & Africa Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2024-2031
11.5.3. Middle East & Africa Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
11.5.4. Middle East & Africa Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Sterility Type, 2024-2031
11.5.5. Middle East & Africa Compounding Pharmacy Market Revenue (US$ Million) Estimates and by End User, 2024-2031
11.5.6. Middle East & Africa Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by Compounding Type, 2024-2031
11.5.7. Middle East & Africa Compounding Pharmacy Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Albertsons Companies
12.2.2. Apollo Clinical Pharmacy
12.2.3. Aurora Compounding
12.2.4. B. Braun Melsungen
12.2.5. Custom Med Apothecary
12.2.6. Fresenius Kabi
12.2.7. Fagron
12.2.8. Formul8
12.2.9. Fusion Apothecary
12.2.10. Galenic Laboratories (Roseway Labs)
12.2.11. Institutional Pharmacy Solutions
12.2.12. JL Diekman and AQ Touchard
12.2.13. Letco Medical
12.2.14. Olympia Pharmacy
12.2.15. PharMEDium Services
12.2.16. Walgreen
12.2.17. Wedgewood Pharmacy
12.2.18. The London Specialist Pharmacy Ltd
12.2.19. MEDS Pharmacy
12.2.20. Rx3 Compounding Pharmacy
12.2.21. Clinigen Group PLC
12.2.22. Dougherty's Pharmacy, Inc.
12.2.23. Lorraine's Pharmacy
12.2.24. Mcguff compounding pharmacy services
12.2.25. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們